Healthcare

LeMaitre Vascular, Inc.(LMAT)

Live Price

Offline

$93.93

+1.82% today

1Y Change

+14.02%

Window

Jun 26, 2025 → Jun 18, 2026

Market Cap: $2.54B
Revenue Growth: +13.5%
EPS Growth: +30.1%
Dividend Yield: 0.8%

Coverage: 246 bars · Jun 26, 2025 → Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

LeMaitre Vascular, Inc. (LMAT) is a Healthcare stock with a market cap of $2.54B and listed on NASDAQ. The stock last traded around $93.93 and up 14.0% across the available one-year price window (Jun 26, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +13.5%, EPS growth of +30.1%, a dividend yield of 0.8%. What stands out right now is revenue +13.5%, EPS +30.1%, free cash flow +100.4% with operating margin 27.2% and ROIC 9.0%. The dividend is present but secondary, with a yield around 0.8%. Valuation already assumes a fairly strong business story at P/E 43.9 and price/sales 10.2. Stock Foundry combines LMAT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

LMAT vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

LMAT

—

Normalized return

SPY

S&P 500

Excess Return

Relative to SPY

LMAT Max Drawdown

-22.12%

Trailing 1Y

SPY Max Drawdown

—

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for LMAT and SPY.

Calendar-year return history is still loading or unavailable.

Unable to load analyst forecasts.

Timed out loading forecasts for LMAT

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.

Read the analyst forecasts guide Compare stocks with this setup